Chemotherapy as language: Sound symbolism in cancer medication names

Social Science and Medicine

Volumn 66, Issue 8, 2008, Pages 1863-1869

  Abel, Gregory A ^a   Glinert, Lewis H ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b DARTMOUTH COLLEGE   (United States)

Author keywords

Cancer; Chemotherapy; Marketing; Medications; Oncology; Psycholinguistics; Sound symbolism

Indexed keywords

AMIFOSTINE; ANASTROZOLE; ANTINEOPLASTIC AGENT; BEVACIZUMAB; BICALUTAMIDE; BLEOMYCIN; BLEOMYCIN SULFATE; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ERYTHROPOIETIN; ESTRAMUSTINE; ESTRAMUSTINE PHOSPHATE SODIUM; ETOPOSIDE; EXEMESTANE; FLOXURIDINE; FLUDARABINE; FLUDARABINE PHOSPHATE; FLUOROURACIL; FLUTAMIDE; FOLINATE CALCIUM; GEMCITABINE; GOSERELIN; HYDROXYUREA; IFOSFAMIDE; IRINOTECAN; KETOCONAZOLE; LETROZOLE; LEUPRORELIN; MEGESTROL ACETATE; MELPHALAN; MERCAPTOPURINE; MESNA; METHOTREXATE; MITOXANTRONE; NAVELBINE; OXALIPLATIN; PACLITAXEL; PAMIDRONIC ACID; PROCARBAZINE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 2; RITUXIMAB; STERAPRED; TAMOXIFEN CITRATE; TEMOZOLOMIDE; THALIDOMIDE; THIOTEPA; TOPOTECAN; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE SULFATE; VINCRISTINE SULFATE;

CANCER; CHEMOTHERAPY; MARKETING; SYMBOLISM;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; DRUG MARKETING; DRUG NOMENCLATURE; EMOTION; LANGUAGE; LINGUISTICS; SOUND; SYMBOLISM;

ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; PSYCHOLINGUISTICS; SYMBOLISM; TERMINOLOGY AS TOPIC;

EID: 40749144451     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2007.12.016     Document Type: Article

References (34)

1. Ainsworth-Vaughn N. Claiming power in doctor-patient talk (1988), Oxford University Press, Oxford
2. Baciu A., Stratton K., and Burke S. The future of drug safety: Promoting and protecting the health of the public. Committee on the Assessment of the US Drug Safety System Board on Population Health and Public Health Practice (2006), Institute of Medicine, The National Academies Press, Washington, D.C.
3. Bolinger D. Aspects of language (pp. 22ff, 217ff) (1975), Harcourt Brace Jovanovich, New York
4. Boslet M. It's Alive! It's Also Small, Simple: The Ideas Behind the Name 'Zune'. The Wall Street Journal (November 16, 2006) B3 New York
5. Bowles H. The semantic properties of the phonaestheme. Studi Italiani di Linguistica Teorica e Applicata 24 1 (1995) 91-106
6. Browall M., Gaston-Johansson F., and Danielson E. Post-menopausal women with breast cancer: their experiences of the chemotherapy treatment period. Cancer Nursing 29 1 (2006) 34-42
7. Buckalew L., and Sallis R. Patient compliance and medication perception. Journal of Clinical Psychology 42 1 (1986) 49-53
8. Carlick A., and Biley F.C. Thoughts on the therapeutic use of narrative in the promotion of coping in cancer care. European Journal of Cancer Care 13 4 (2004) 308-317
9. Carterette E., and Jones M. Informal speech: Alphabetic and phonemic texts with stastistical analyses and tables (1974), University of California Press, Berkeley
10. Chadia N., and Repanos R. Patients' understanding of words used to describe lumps: a cross-sectional study. The Journal of Laryngology and Otology 120 (2006) 125-128
11. Charon R. Narrative medicine: Honoring the stories of illness (2006), Oxford University Press, New York
12. Conrad P. The meaning of medications: another look at compliance. Social Science & Medicine 20 1 (1994) 29-37
13. GAO. Prescription drugs: improvements needed in FDA's oversight of direct-to-consumer advertising. In: U.S.G.A. Office (Ed). Report to congressional requesters (2006), United States Government Accountability Office, Washington, DC 1-19
14. Gunderson L. The complex process of naming drugs. Annals of Internal Medicine 129 8 (1998) 677-678
15. Karp D. The meanings of medications. In: Karp D. (Ed). Speaking of sadness (1996), Oxford University Press, New York 79-103
16. Keller K., Heckler S., and Houston M. The effects of brand name suggestiveness on advertising recall. Journal of Marketing 62 (1998) 48-57
17. Klink R. Creating brand names with meaning: the use of sound symbolism. Marketing Letters 11 1 (2000) 5-20
18. Ladefoged P. American English, Handbook of the International Phonetic Association (1999), Cambridge University Press, Cambridge, UK pp. 41-44
19. Lambert B.L., Chang K.Y., and Lin S.J. Effect of orthographic and phonological similarity on false recognition of drug names. Social Science & Medicine 52 12 (2001) 1843-1857
20. Lowrey T., Shrum L., and Dubitsky T. The relationship between brand-name linguistic characteristics and brand-name memory. Journal of Advertising 32 3 (2003) 7-17
21. McNeil D. The Science of Naming Drugs (Sorry, 'Z' Is Already Taken). The New York Times (December 28, 2003) (p. 10), New York
22. Montagne M. The metaphorical nature of drugs and drug taking. Social Science & Medicine 26 (1988) 417-424
23. Newman S. Further experiments in phonetic symbolism. American Journal of Psychology 45 (1933) 53-75
24. Nöth W. Semiotic foundations of iconicity in language and literature. In: Fischer O., and Nänny M. (Eds). The motivated sign: Iconicity in language and literature (2001), John Benjamins, Amsterdam 17-28
25. Ohala J. The frequency code underlies the sound-symbolic use of voice pitch. In: Hinton L., Nichols J., and Ohala J. (Eds). Sound symbolism (1994), Cambridge University Press, Cambridge 325-347
26. Pellegrino E.D. Prescribing and drug ingestion symbols and substances. Drug Intelligence & Clinical Pharmacy 10 (1976) 624-630
27. Reagan B. The cure for confusion. The Wall Street Journal (November 11, 2002) R6 New York
28. Sapir E. A study in phonetic symbolism. Journal of Experimental Psychology 12 (1929) 225-239
29. Southerland H., Lockwood G., Tritchler D., Sem F., Brooks L., and Till J. Communicating probabilistic information to cancer patients: is there 'noise' on the line?. Social Science & Medicine 32 6 (1991) 725-731
30. Tarn D.M., Heritage J., Paterniti D.A., Hays R.D., Kravitz R.L., and Wenger N.S. Physician communication when prescribing new medications. Archives of Internal Medicine 166 17 (2006) 1855-1862
31. Trostle J.A. Medical compliance as an ideology. Social Science & Medicine 27 12 (1988) 1299-1308
32. Vuckovic N., and Nichter M. Changing patterns of pharmaceutical practice in the United States. Social Science & Medicine 44 9 (1997) 1285-1302
33. WHO. Guidance on international non-proprietary names (2006), World Health Organization
34. Yorkston E., and Menon G. A sound idea: phonetic effects of brand names on consumer judgments. Journal of Consumer Research 31 (2004) 43-51